I use a discounted cash flow model. Like any valuation model it is only as good as the assumptions that you put in! The model itself is simple. Enter cashflows for each half year / year of your forecast range, pick a discount rate and discount all of the cashflows back to year zero (ie the present). Then as we were discussing above you need to come up with a value for the cashflows outside of the forecast period or you at least a proxy for the net value of the assets of the company.I'm curious to know with whatever fundamental, value, cash flow method you use, how do you come to a price you are willing to buy at?
I'm afraid I wouldn't post my own as a) it would be useless to anyone who had not made the assumptions within (ie. probably everyone but me!) and b) I don't want people relying on the figures.Are you able to give an example?
It find it an enjoying challenge - most companies I look at I will never value. The DCF model is the very last input, if I cannot find anything to get too excited about (which is the vast majority) then I move on in peace. Perhaps make a note for future review.It just seems like a lot of analysis without reaching a final figure.
I use a discounted cash flow model. Like any valuation model it is only as good as the assumptions that you put in! The model itself is simple. Enter cashflows for each half year / year of your forecast range, pick a discount rate and discount all of the cashflows back to year zero (ie the present). Then as we were discussing above you need to come up with a value for the cashflows outside of the forecast period or you at least a proxy for the net value of the assets of the company.
A model may look like:
http://www.stern.nyu.edu/~adamodar/pc/eqegs/Brahma.xls
This is from Aswath Damodaran.
I'm afraid I wouldn't post my own as a) it would be useless to anyone who had not made the assumptions within (ie. probably everyone but me!) and b) I don't want people relying on the figures.
It find it an enjoying challenge - most companies I look at I will never value. The DCF model is the very last input, if I cannot find anything to get too excited about (which is the vast majority) then I move on in peace. Perhaps make a note for future review.
I usually only spend an hour (or two max) per night on research, so it's not too strenuous.
Aswath Damodaran has some good papers on his site. He covers all bases. Just beware it isn't highly organised (well I don't think it is) but if you want to start from scratch it's a good free source.Is there a preferred method for growth stocks? As I know that's what I have a bias towards, in my trading.
Aswath Damodaran has some good papers on his site. He covers all bases. Just beware it isn't highly organised (well I don't think it is) but if you want to start from scratch it's a good free source.
He also has a book called "Little Book of Valuation" which covers the basics of this and other models / methods. I picked it up for about $20 in store. Probably cheaper online!
The best way to think of a model is merely a way of expressing the cash flows - there may be a growth period in the initial years, then a maturing period, then stable growth.... or the whole business could be very cyclical. Learn the maths (or how to program MS Excel) and you can build your own easily. The NPV function in Excel is great.
Here’s an Ironic post for a stock forum.
The best way to think about investments is to be in a room with no one else and just think.
http://www.youtube.com/watch?v=aL766NK2ynw
I think he’s trying to tell me something.
The market got complacent at $18 which really was perfect-sunshine-forever valuation.
MMS has been pretty fully priced on and off for quite a while. But the price largely run in line with the underlying business results and without knowing a certain end date for novated leasing (which seemed de-risked with the implementation of the Henry recommendations) the overpricing never really amounted to enough to compensate for tax and give a MOS on the sell decision. (note: some were sold purely on max position size rules)
There has, at times, been a disconnect between growth in revenue and EBIT, and stock price performance, with the primary reason for this being regulation. Given the risk of regulatory change is real and material, the MMS stock price is volatile when the issue of regulatory change arises. UItimately, differentiation must be made between actual and perceived risk. We agree that perceived risk is very high, however our view is that actual risk is often materially overstated. As time passes and the likelihood of certain perceived risks materializing into actual risks minimizes, the stock frequently re-rates or at worst, returns to its previous levels.
I’ve reflected on this investment and am happy with the entry decision, position sizing and the trade management, however I’m a bit close for an unbiased POV so would be pleased to see you extend the complacency argument for MMS. If the charge of complacency is valid this is the damage I have needlessly incurred. – The equity curve for the super account where this investment sits. (the trading to mitigate is in another account) July drawdown basically = MMS.
I sold these back at ~$6 so I am not very good at pricing that risk (or the market is wrong)...
Bumping this old post. Apologies for the grave-digging.The companies I hold or are really interested in, I model their financial reports and project them forward based on my assumptions. Those assumptions and how well I can make them is where earnings risk comes into play. My valuation is simply to run an IRR on the bottom line to determine the projected yield. The yield is determined without the sale of the asset, but a terminal valuation is included at the end of the cash flow projections, that terminal value is normally the replacement value of the physical assets unless I am absolutely convinced the company has a sustainable competitive advantage, in which case It will be some sort of multiple of replacement asset value.
Thank you for the explanation via PM - it does give me a starting point for my questions here and a bit of the reasoning that goes in behind it.I lost my reply to your post below with some error 520 (and it still wont let me reply to it) . - It was a very similar answer to my response to your PM - did that sort this one out a bit for you as well? If not I'll type up again tomorrow.
Cheers
Some more reflection on MMS investment.
MMS re-acquainted me with scalability issues in absolute dollar terms. Relevance, percentage thinking etc etc all fine until your bloody brain starts involuntarily obsessing on volatility calculated in terms of X number of years of average wages; donation; cars; houses; planes; boats; holidays whatever your measurement unit of meaningfulness may be.
Final wash up I am only going to make 1 change to my approach which led MMS to appear and stay in my portfolio and that is to adjust maximum portfolio exposure for known tail risk. Long term I expect this to be a compromise in total returns (just as any arbitrary capping of winners is likely to do) but at this stage I’m willing to pay for a bit of emotional comfort and facilitate a more relaxed position from which to monitor developments.
I don't know about you - but this is probably the worst "psychological" stock in my portfolio at the moment.Some more reflection on MMS investment.
Buffett's idea of only visiting Wall Street once a year resonates highly with me at times like these. Clearer, precise thinking, free of everyone else's emotions, plans, angles, yada yada. The dark room sounds good to me at the moment.
I've made a conscious effort as part of my New Financial Year's resolution to try and reduce the amount of crowd sourced opinions I listen to.
The best way to think about investments is to be in a room with no one else and just think.
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.